OTCMKTS:CSLLY

Commonwealth Bank of Australia Stock Forecast, Price & News

$110.25

-2.64 (-2.34 %)

(As of 11/30/2020 04:00 PM ET)

Add

Compare

Today's Range

$110.18

Now: $110.25▼

$111.28

50-Day Range

$101.34

MA: $109.05▼

$117.74

52-Week Range

$75.19

Now: $110.25▼

$117.98

Volume44,162 shs

Average Volume48,600 shs

Market Capitalization$100.32 billion

P/E Ratio47.73

Dividend Yield0.86%

Beta0.6

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Commonwealth Bank of Australia.

2.0 Community Rank

Outperform Votes
Commonwealth Bank of Australia has received 36 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Commonwealth Bank of Australia has received 56 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Commonwealth Bank of Australia has received 60.87% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Commonwealth Bank of Australia and other stocks. Vote “Outperform” if you believe CSLLY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CSLLY will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
Commonwealth Bank of Australia has a dividend yield of 0.86%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Commonwealth Bank of Australia does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Commonwealth Bank of Australia is 41.99%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Commonwealth Bank of Australia will have a dividend payout ratio of 35.66% next year. This indicates that Commonwealth Bank of Australia will be able to sustain or increase its dividend.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Commonwealth Bank of Australia insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.07% of the stock of Commonwealth Bank of Australia is held by institutions.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Commonwealth Bank of Australia are expected to grow by 8.80% in the coming year, from $2.50 to $2.72 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Commonwealth Bank of Australia is 47.73, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.70.
Price to Earnings Ratio vs. Sector
The P/E ratio of Commonwealth Bank of Australia is 47.73, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.05.
Price to Book Value per Share Ratio
Commonwealth Bank of Australia has a P/B Ratio of 15.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.98 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:CSLLY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.csl.com.au

Phone61-3-9389-1911

Employees27,000

Debt

Debt-to-Equity Ratio0.89

Current Ratio3.01

Quick Ratio1.37

Price-To-Earnings

Trailing P/E Ratio47.73

Forward P/E Ratio44.10

P/E GrowthN/A

Sales & Book Value

Annual Sales$9.15 billion

Price / Sales10.96

Cash Flow$2.67 per share

Price / Cash Flow41.35

Book Value$7.19 per share

Price / Book15.33

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares909,939,000

Market Cap$100.32 billion

Next Earnings DateN/A

OptionableNot Optionable

$110.25

-2.64 (-2.34 %)

(As of 11/30/2020 04:00 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CSLLY News and Ratings via Email

Sign-up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter.

Commonwealth Bank of Australia (OTCMKTS:CSLLY) Frequently Asked Questions

How has Commonwealth Bank of Australia's stock price been impacted by Coronavirus?

Commonwealth Bank of Australia's stock was trading at $101.09 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CSLLY stock has increased by 9.1% and is now trading at $110.25.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Commonwealth Bank of Australia?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Commonwealth Bank of Australia in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Commonwealth Bank of Australia or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Commonwealth Bank of Australia?

Wall Street analysts have given Commonwealth Bank of Australia a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Commonwealth Bank of Australia wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Commonwealth Bank of Australia?

Commonwealth Bank of Australia saw a increase in short interest in October. As of October 30th, there was short interest totaling 27,300 shares, an increase of 25.2% from the October 15th total of 21,800 shares. Based on an average daily trading volume, of 66,700 shares, the short-interest ratio is presently 0.4 days.
View Commonwealth Bank of Australia's Short Interest.

Who are some of Commonwealth Bank of Australia's key competitors?

Some companies that are related to Commonwealth Bank of Australia include Johnson & Johnson (JNJ), Roche (RHHBY), Pfizer (PFE), Novartis (NVS), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), AbbVie (ABBV), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), Eli Lilly and (LLY), AstraZeneca (AZN), AstraZeneca (AZN), Sanofi (SNY), Sanofi (SNY) and GlaxoSmithKline (GSK).
View all competitors.

Who are Commonwealth Bank of Australia's key executives?

Commonwealth Bank of Australia's management team includes the following people:

Mr. Paul R. Perreault B.A., MD, CEO & Exec. Director (Age 63, Pay $4.23M)
Dr. Paul F. McKenzie, Chief Operating Officer (Age 54, Pay $2.74M)
Dr. Robert Andrew Cuthbertson A.O., BMedSci, MBBS, Ph.D., FTSE, FAHMS, AO, Sr. Adviser & Exec. Director (Age 65, Pay $1.48M)
Ms. Joy Carolyn Linton BComm, Grad Dip AFI, GAICD, Chief Financial Officer (Age 55)
Mr. Mark Dehring, Head of Investor Relations
Mr. Gregory Boss B.S., BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel (Age 59)
Christina Hickie, Sr. Mang. of Communications
Ms. Elizabeth Walker B.A., M.S., Exec. VP & Chief HR Officer (Age 50)
Dr. Karen Etchberger, Exec. VP of Quality & Bus. Services (Age 62)
Ms. Sharon McHale, Head of Public Affairs

What is Commonwealth Bank of Australia's stock symbol?

Commonwealth Bank of Australia trades on the OTCMKTS under the ticker symbol "CSLLY."

How do I buy shares of Commonwealth Bank of Australia?

Shares of CSLLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Commonwealth Bank of Australia's stock price today?

One share of CSLLY stock can currently be purchased for approximately $110.25.

How big of a company is Commonwealth Bank of Australia?

Commonwealth Bank of Australia has a market capitalization of $100.32 billion and generates $9.15 billion in revenue each year. The company earns $2.10 billion in net income (profit) each year or $2.31 on an earnings per share basis. Commonwealth Bank of Australia employs 27,000 workers across the globe.

What is Commonwealth Bank of Australia's official website?

The official website for Commonwealth Bank of Australia is www.csl.com.au.

How can I contact Commonwealth Bank of Australia?

Commonwealth Bank of Australia's mailing address is 45 Poplar Road, Parkville C3, 3052. The company can be reached via phone at 61-3-9389-1911 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings